5:08 PM
 | 
Jan 11, 2010
 |  BC Extra  |  Company News

sanofi, KaloBios in infectious deal

KaloBios Pharmaceuticals Inc. (South San Francisco, Calif.) granted Sanofi Pasteur S.A. exclusive, worldwide rights to develop and commercialize KB001 to treat and prevent Pseudomonas...

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >